Fasting insulin measures the level of insulin circulating in your blood after an 8-hour fast. When glucose control is good, fasting insulin is low because the body doesn't need to work hard to maintain glucose balance in a fasted state.
Fasting insulin is one of the most sensitive early markers of metabolic dysfunction. It often rises years before fasting glucose or HbA1c begin to shift. The longevity consensus targets under 5 µIU/mL, with 2-5 reflecting optimal insulin sensitivity. Elevated fasting insulin with normal glucose indicates the body is working harder to maintain balance, and this pattern is a strong signal to intervene before progression. Insulin is rarely tested in standard clinical workups but is central to longevity-focused metabolic assessment.
Optimal Fasting Insulin: 2-5 µU/mL.
Typically re-tested every 10 weeks.
Insulin is not a pass or fail number. The same value can mean quite different things depending on your glucose, your body composition and what you did in the 24 hours before the blood draw.
Fasting insulin is a blood test that measures how much insulin is circulating in your bloodstream after an overnight fast, usually reported in µU/mL (also written µIU/mL).
Insulin is made by the beta cells of the pancreas. After a meal it rises sharply to move glucose out of the bloodstream into muscle and fat cells, to signal the liver to stop producing glucose of its own, and to slow the release of stored fat. Between meals and overnight, secretion falls back to a low background level whose main job is keeping the liver's glucose output in check. A fasting measurement captures that background level, not the post-meal surge.
The number becomes informative when cells stop responding briskly to insulin's signal. The pancreas compensates by releasing more, and for a long time that compensation works, so glucose readings can look unremarkable while insulin climbs quietly in the background. Research into the mechanisms behind reduced insulin sensitivity points to changes in receptor and post-receptor signalling, fat accumulation in liver and muscle tissue, and inflammatory signalling[1]. Insulin is still an indirect measure. Commentary in the clinical literature has long cautioned that insulin assays differ between laboratories and that a single insulin value is an imperfect stand-in for what is happening inside tissue[2].
Fasting insulin matters because it is one of the earlier blood markers to shift when the body starts compensating for reduced insulin sensitivity, often while fasting glucose and HbA1c still read as ordinary.
Glucose is a relatively late signal. It stays near target for as long as the pancreas can keep raising output to hold it there, which means a normal glucose result does not, on its own, tell you how much insulin effort is behind it. Modelling work describing the progression of type 2 diabetes links body weight, insulin, glucose and HbA1c as parts of one changing system rather than four independent numbers[3]. Seeing the insulin side of that system gives you earlier information than glucose alone.
Insulin handling also travels closely with liver fat. Research in children with nonalcoholic fatty liver disease has examined circulating metabolic markers alongside insulin measures, reflecting how tightly liver fat and insulin sensitivity are connected[4]. In adults, higher fasting insulin is commonly discussed alongside the familiar cardiometabolic cluster of raised triglycerides, lower HDL, higher blood pressure, higher uric acid and low-grade inflammation.
None of that makes fasting insulin a diagnostic test. It is a direction indicator. A single value interpreted in isolation can mislead, which is why the trend across repeated tests, read next to glucose and lipids, carries more weight than any one morning's result.
Most laboratories regard roughly 2 to 18 µU/mL as a typical adult reference range for fasting insulin, while FitScript's optimal range is narrower at 2 to 5 µU/mL.
| Measure | Typical lab reference range | FitScript optimal range |
|---|---|---|
| Fasting insulin, adults | 2 to 18 µU/mL | 2 to 5 µU/mL |
Fasting insulin results from 21,684 adults aged 20 to 60 in Rio de Janeiro, Brazil, were mined from a large laboratory database. Women ran slightly higher than men at the upper end.[13]
| Sex | Age | Reference range (µU/mL) |
|---|---|---|
| Women | 20 to 60 | 2.54 to 13.30 |
| Men | 20 to 60 | 2.43 to 11.89 |
| All | 20 to 60 | 2.52 to 13.14 |
These are 95% reference intervals by sex, measured by electrochemiluminescence immunoassay; the authors concluded the overall interval can be applied to both sexes. Your own lab's printed range is the one to read your result against.
Typical lab reference ranges vary by laboratory, assay, age and sex, so always read your own report's stated range. FitScript's optimal range is an optimization target, not a diagnostic cut-off, and a result outside it is not a diagnosis of anything. No age-banded optimal range is published for this marker here, so treat the adult figures above as general rather than age-specific.
The gap between the two columns is worth understanding. A standard reference range describes the spread of values found in the population that gets tested, which includes a wide mix of metabolic health. An optimal range describes where values tend to sit in people with high insulin sensitivity. That is why a result of 14 µU/mL can be flagged as normal by a laboratory and still be suboptimal from an optimization point of view.
Some labs report insulin in pmol/L rather than µU/mL. The two are related by a conversion factor of roughly 6, so check your units before comparing results from different laboratories. Because assays are not uniformly standardised[2], comparing an insulin value from one lab with one from another can introduce differences that have nothing to do with your physiology.
A fasting insulin above the optimal range, and particularly above the standard reference range, generally suggests the pancreas is releasing more insulin than average to hold glucose steady, a pattern clinicians describe as reduced insulin sensitivity rather than as a specific disease.
Many people with higher fasting insulin report nothing at all. Others describe energy dips an hour or two after meals, hunger returning quickly, strong carbohydrate cravings, difficulty losing fat around the midsection, or skin changes such as skin tags and darker velvety patches in the neck and armpit folds, which are commonly associated with insulin resistance. Symptoms are suggestive, never confirmatory.
Common contributors include excess visceral fat, low physical activity, short or fragmented sleep, sustained psychological stress, a dietary pattern heavy in refined carbohydrate and alcohol, and certain medications such as some psychiatric medications. Physiological states matter too. Insulin sensitivity falls naturally during puberty and during pregnancy, and reviews of the insulin resistance of puberty describe it as a normal, temporary shift that usually reverses once puberty ends[5]. Polycystic ovary syndrome is another condition in which insulin resistance is frequently described, and a Mendelian randomization study with meta-analysis suggests that adiposity in childhood, adolescence and adulthood is associated with risk of PCOS[6].
Over the long term, persistently elevated fasting insulin is associated with the trajectory toward type 2 diabetes, with fat accumulation in the liver, and with the lipid and inflammatory patterns that cluster around metabolic dysfunction[3]. The sensible next step after a single high reading is to repeat the test under properly fasted conditions and review it with a clinician alongside glucose, HbA1c and lipids. A high insulin accompanied by elevated glucose, or by symptoms such as excessive thirst, frequent urination or unexplained weight loss, is worth discussing with a clinician promptly.
A low fasting insulin alongside a normal fasting glucose usually reflects good insulin sensitivity, which clinicians generally regard as favourable; a low insulin alongside elevated glucose is a different picture, because it can reflect reduced insulin production rather than efficient insulin use.
In the first scenario people typically report no symptoms, which is the point. In the second, the symptoms described are those of insufficient insulin action, including thirst, frequent urination, unintended weight loss, fatigue and blurred vision. That combination is worth discussing with a clinician promptly rather than monitoring at home.
Common reasons for a low value include being lean and physically active, a long fast or a very low carbohydrate intake in the days before the draw, substantial recent weight loss, and reduced beta cell output as seen in type 1 diabetes and in long-standing type 2 diabetes. Pancreatic conditions and some medications can also lower circulating insulin. Laboratory factors matter as well, since exogenous insulin and anti-insulin antibodies can interfere with how some assays read a sample.
Long term, a low fasting insulin that sits beside normal glucose, healthy lipids and a stable body composition generally tracks with favourable metabolic markers. A low value that arrives alongside inadequate food intake, acute illness or rising glucose is not the same thing and should not be read as a win. As with a high result, interpret it next to glucose and HbA1c, and discuss a persistently low or unexpected result with a clinician instead of dismissing it.
Fasting insulin is one of the more condition-sensitive blood markers, so the state you arrive in, the medications you take and your habits over preceding weeks can all move the number.
For testing conditions, the usual approach is a morning draw after 8 to 12 hours without food, water allowed. Intense exercise the previous evening, alcohol, a short night of sleep, acute illness and acute stress can all shift the result, and so can drawing the sample at a different time of day. Because insulin assays are not uniformly standardised, results from two different laboratories are not strictly interchangeable[2], which is a strong argument for retesting the same way at the same lab.
Habits move the marker over weeks and months rather than days. Changes in body fat, particularly visceral fat, regular resistance and aerobic activity, sleep duration and dietary pattern are the levers most consistently discussed. The effect of specific foods is less certain than headlines suggest. A systematic review and meta-analysis of sesame consumption found favourable effects on blood glucose measures but not on insulin resistance indices[7], a useful reminder that an intervention can shift one marker without shifting another. Reviews of the gut microbiome describe links between gut bacteria, low-grade inflammation and insulin resistance[8], and a network meta-analysis has compared acupuncture methods in obesity with insulin resistance[9]; both remain developing areas rather than settled ones. Detailed day-to-day strategy sits in FitScript's separate question and answer guide for this marker.
Medications are a frequent and under-appreciated influence. Thiazolidinediones have been studied in nonalcoholic steatohepatitis in a meta-analysis of randomised clinical trials[10], a trial of semaglutide in adolescents with obesity reported effects on insulin sensitivity and cardiometabolic risk factors[11], and modelling work for the GLP-1 receptor agonist lixisenatide describes how drug and disease interact in type 2 diabetes[12]. A licensed provider evaluates whether any prescription option is appropriate for an individual, and this page gives no doses, schedules or administration guidance. Tell whoever interprets your result about every medication and supplement you take.
FitScript measures fasting insulin within its metabolic lab work, inside a membership built around 150+ biomarkers tested per year. Atlas, FitScript's AI health advisor, reads the insulin value in context with glucose, HbA1c, lipids and inflammation markers rather than as a standalone number, and writes your FitScript from that combined picture. Because this marker responds to sleep, training and the previous day's eating, repeat testing under consistent conditions is what makes the trend readable. Where a prescription option enters the conversation, a licensed provider reviews the member and decides whether it is appropriate.
Fasting insulin is most informative when read next to the markers that describe the same system from different angles, which is why it is rarely ordered alone.
Fasting Glucose is the other half of the picture. Insulin tells you the effort; glucose tells you the result of that effort. A normal glucose with a high insulin reads very differently from a normal glucose with a low insulin.
HOMA-IR combines fasting insulin and fasting glucose into a single index of insulin resistance, which is often easier to track over time than either number alone.
Hemoglobin A1C reflects average glucose exposure over the preceding months, adding a longer time horizon to a single morning's insulin and glucose snapshot.
Triglyceride/HDL Ratio is a lipid pattern frequently discussed alongside insulin resistance, and it is calculated from a standard lipid panel you likely already have.
C-Reactive Protein tracks low-grade inflammation, which is part of the mechanistic picture described in insulin resistance research[1].
Uric Acid is another marker commonly found alongside the metabolic cluster, and it is inexpensive to include on the same draw.
Fasting insulin measures the background insulin your body needs to keep glucose steady overnight. Typical lab reference ranges run to roughly 18 µU/mL, FitScript's optimal range is 2 to 5 µU/mL, and the space between those two is where most of the useful information lives. Read the number with glucose, repeat it under the same conditions, and watch the direction it moves. This page is educational and is not medical advice. Discuss your results, and any treatment option, with a clinician or licensed provider who can review your full history.
The Metabolic + Insulin panel is where this marker is measured alongside the companion markers described above.
Calculators that use Fasting Insulin:
Most laboratories ask for 8 to 12 hours without food, with water allowed, and a morning draw. Follow the instructions your own lab gives, since the fasting window is part of what makes the result comparable to your previous tests.
Plain water is normally fine and helps the draw go smoothly. Coffee, even black, can influence metabolic readings, so it is usually left until after the blood is taken. Confirm with the lab or clinician ordering the test.
Typical lab reference ranges run roughly 2 to 18 µU/mL, and FitScript's optimal range is 2 to 5 µU/mL. Optimal ranges are optimization targets rather than diagnostic cut-offs, and ranges vary by lab, age and sex, so read your own report's stated range.
Glucose often stays in range for years because rising insulin keeps it there. Measuring insulin shows how much effort sits behind a normal glucose reading, which is information a glucose test alone cannot give you.
No single value confirms anything. A high result is a signal to repeat the test under properly fasted conditions and review it with a clinician alongside glucose, HbA1c and lipids before drawing any conclusion.
It can. Sleep loss, acute stress, illness, alcohol and hard training the evening before are all associated with shifts in insulin readings, which is why consistent testing conditions matter for tracking the trend.
Yes. Fasting glucose, HOMA-IR, HbA1c, the triglyceride to HDL ratio, C-reactive protein and uric acid each describe part of the same metabolic picture, and interpreting insulin without them is guesswork.
They can. Tell whoever interprets your result about everything you take, and let a licensed provider decide whether any prescription option is appropriate.